Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.58 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.52 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.47 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.47 |
| ▸ | BID | P55957 | 3/20 | 0.45 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.45 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.45 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.45 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 1/20 | 0.45 |
| ▸ | EP300 | Q09472 | 1/20 | 0.45 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.45 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.45 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.45 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.45 |
| ▸ | THRA | P10827 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10383680 | 1.00 | LIPG (0.58) | LIPGTAAR1NR1H2NR1H3BID | |
| SCHEMBL8766460 | 1.00 | LIPG (0.58) | LIPGTAAR1NR1H2NR1H3BID | |
| SCHEMBL5599119 | 1.00 | LIPG (0.58) | LIPGTAAR1NR1H2NR1H3BID | |
| SCHEMBL31591865 | 1.00 | LIPG (0.58) | LIPGTAAR1NR1H2NR1H3BID | |
| SCHEMBL14636127 | 1.00 | LIPG (0.58) | LIPGTAAR1NR1H2NR1H3BID | |
| SCHEMBL9835429 | 1.00 | LIPG (0.58) | LIPGTAAR1NR1H2NR1H3BID | |
| SCHEMBL27574851 | 1.00 | LIPG (0.58) | LIPGTAAR1NR1H2NR1H3BID | |
| SCHEMBL28299135 | 1.00 | LIPG (0.58) | LIPGTAAR1NR1H2NR1H3BID | |
| SCHEMBL31591893 | 1.00 | LIPG (0.58) | LIPGTAAR1NR1H2NR1H3BID | |
| SCHEMBL5599418 | 1.00 | LIPG (0.58) | LIPGTAAR1NR1H2NR1H3BID |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110627831-A | Bibiaryl acetal phosphines, their preparation and use in coupling reactions | 东莞市均成高新材料有限公司 | 2019-12-31 | — | — | CN | disclosed |
| US-20160359116-A1 | Organic Semiconductor Formulations | SMARTKEM LIMITED (GB) | 2016-12-08 | — | — | US | disclosed |
| CN-1930145-B | Cycloalkanopyridine derivative | MSD CO LTD | 2011-06-15 | — | — | CN | disclosed |
| CN-1930145-A | Cycloalkanopyridine derivative | BANYU PHARMA CO LTD (JP) | 2007-03-14 | — | — | CN | disclosed |
| CN-1266098-C | Substituted dicyclohexylalkyl diphenyl derivative with good low-tomp, mutual solubility, its preparation and application | SHIJIAZHUANG YONGSHENG HUATSIN (CN) | 2006-07-26 | — | — | CN | disclosed |
| EP-1499604-A1 | DIHYDROBENZOFURAN AND DIHYDROBENZOTHIOPHENE 2,4-PENTAIDENOIC ACID DERIVATIVES HAVING SELECTIVE ACTIVITY FOR RETINOID X (RXR) RECEPTORS | Allergan, Inc. (US) | 2005-01-26 | — | — | EP | disclosed |
| US-6720423-B2 | SKIN RELATED DISEASES; PROMOTE THE EXPRESSION OF OR BIND TO RECEPTORS BELONGING TO THE STEROID OR THYROID RECEPTOR SUPERFAMILY. | ALLERGAN, INC. | 2004-04-13 | — | — | US | disclosed |
| CN-1477089-A | Substituted dicyclohexylalkyl diphenyl derivative with good low-tomp, mutual solubility, its preparation and application | 石家庄实力克液晶材料有限公司 | 2004-02-25 | — | — | CN | disclosed |
| US-20030216570-A1 | Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors | ALLERGAN, INC. | 2003-11-20 | — | — | US | disclosed |
| WO-2003093257-A1 | DIHYDROBENZOFURAN AND DIHYDROBENZOTHIOPHENE 2,4-PENTAIDENOIC ACID DERIVATIVES HAVING SELECTIVE ACTIVITY FOR RETINOID X (RXR) RECEPTORS | ALLERGAN, INC. (US) | 2003-11-13 | — | — | WO | disclosed |
| US-4554360-A | DIARYLIODONIUM SALT, IODOARENE, COUPLING | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1985-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216570-A1 | Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors | RXRB, RXRA, RXRG | LIPG 3477/4885TAAR1 374/4885NR1H2 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.